市場調査レポート
商品コード
1590402

組織接着剤のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2024年版)

Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


出版日
発行
GlobalData
ページ情報
英文 57 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
組織接着剤のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2024年版)
出版日: 2024年10月18日
発行: GlobalData
ページ情報: 英文 57 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、組織接着剤のパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 組織接着剤 - パイプライン製品:開発段階別
  • 組織接着剤 - パイプライン製品:セグメント別
  • 組織接着剤 - パイプライン製品:地域別
  • 組織接着剤 - パイプライン製品:規制経路別
  • 組織接着剤 - パイプライン製品:推定承認日別
  • 組織接着剤 - 進行中の臨床試験

第4章 組織接着剤 - 各社の開発中のパイプライン製品

  • 組織接着剤企業 - パイプライン製品:開発段階別
  • 組織接着剤 - パイプライン製品:開発段階別

第5章 組織接着剤の企業と製品の概要

  • Adhesys Medical GmbH:企業の概要
    • Adhesys Medical GmbH:パイプライン製品と進行中の臨床試験の概要
  • Advanced Medical Solutions Group plc:企業の概要
    • Advanced Medical Solutions Group plc:パイプライン製品と進行中の臨床試験の概要
  • Aleo BME Inc:企業の概要
    • Aleo BME Inc:パイプライン製品と進行中の臨床試験の概要
  • Alumend LLC:企業の概要
    • Alumend LLC:パイプライン製品と進行中の臨床試験の概要
  • Artivion Inc:企業の概要
    • Artivion Inc:パイプライン製品と進行中の臨床試験の概要
  • BioDevek Inc:企業の概要
    • BioDevek Inc:パイプライン製品と進行中の臨床試験の概要
  • DialyFlux LLC:企業の概要
    • DialyFlux LLC:パイプライン製品と進行中の臨床試験の概要
  • Emory University:企業の概要
    • Emory University:パイプライン製品と進行中の臨床試験の概要
  • Hansjorg Wyss Institute for Biologically Inspired Engineering:企業の概要
    • Hansjorg Wyss Institute for Biologically Inspired Engineering:パイプライン製品と進行中の臨床試験の概要
  • Harvard University:企業の概要
    • Harvard University:パイプライン製品と進行中の臨床試験の概要
  • Kollodis BioSciences Inc:企業の概要
    • Kollodis BioSciences Inc:パイプライン製品と進行中の臨床試験の概要
  • Massachusetts Institute of Technology:企業の概要
    • Massachusetts Institute of Technology:パイプライン製品と進行中の臨床試験の概要
  • Medisse BV(休止中):企業の概要
    • Medisse BV(休止中):パイプライン製品と進行中の臨床試験の概要
  • N8 Medical LLC:企業の概要
    • N8 Medical LLC:パイプライン製品と進行中の臨床試験の概要
  • Nanyang Technological University:企業の概要
    • Nanyang Technological University:パイプライン製品と進行中の臨床試験の概要
  • Northwestern University:企業の概要
    • Northwestern University:パイプライン製品と進行中の臨床試験の概要
  • OptMed Inc:企業の概要
    • OptMed Inc:パイプライン製品と進行中の臨床試験の概要
  • Purdue University:企業の概要
    • Purdue University:パイプライン製品と進行中の臨床試験の概要
  • Tissium SA:企業の概要
    • Tissium SA:パイプライン製品と進行中の臨床試験の概要
  • University of Galway:企業の概要
    • University of Galway:パイプライン製品と進行中の臨床試験の概要
  • University of Kansas:企業の概要
    • University of Kansas:パイプライン製品と進行中の臨床試験の概要

第6章 組織接着剤 - 近年の発展

  • 2024年8月30日:Okapi Medical、Cutiva局所皮膚接着剤の510(k)認可を取得
  • 2024年7月29日:Connexicon Medical、CM005 Standard(CM005)のFDA 510(k)認可を取得
  • 2024年7月29日:Connexicon Medical、CM00622 LINC Skin Closure System(CM00622 LINC)のFDA 510(k)認可を取得
  • 2024年7月29日:Connexicon、CM004 Mini(CM004)のFDA 510(k)認可を取得
  • 2024年3月22日:Meril Endo Surgery、Meriglu Topical Skin AdhesiveのFDA 510(K)認可を取得
  • 2023年10月18日:NeoDyne、英国での成長と拡大を記念して英国本社を新設

第7章 付録

図表

List of Tables

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials
  • Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials
目次
Product Code: GDME1861EPD

GlobalData's Medical Devices sector report, "Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Tissue Adhesives pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. Tissue adhesives allows for proper healing of the wound under the film and protects the wound from microbial infections.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Adhesives under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Adhesives and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Adhesives under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Tissue Adhesives Overview

3 Products under Development

  • 3.1 Tissue Adhesives - Pipeline Products by Stage of Development
  • 3.2 Tissue Adhesives - Pipeline Products by Segment
  • 3.3 Tissue Adhesives - Pipeline Products by Territory
  • 3.4 Tissue Adhesives - Pipeline Products by Regulatory Path
  • 3.5 Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • 3.6 Tissue Adhesives - Ongoing Clinical Trials

4 Tissue Adhesives - Pipeline Products under Development by Companies

  • 4.1 Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • 4.2 Tissue Adhesives - Pipeline Products by Stage of Development

5 Tissue Adhesives Companies and Product Overview

  • 5.1 Adhesys Medical GmbH Company Overview
    • 5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Advanced Medical Solutions Group plc Company Overview
    • 5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Aleo BME Inc Company Overview
    • 5.3.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Alumend LLC Company Overview
    • 5.4.1 Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Artivion Inc Company Overview
    • 5.5.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 BioDevek Inc Company Overview
    • 5.6.1 BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 DialyFlux LLC Company Overview
    • 5.7.1 DialyFlux LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Emory University Company Overview
    • 5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
    • 5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Harvard University Company Overview
    • 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Kollodis BioSciences Inc Company Overview
    • 5.11.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Massachusetts Institute of Technology Company Overview
    • 5.12.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Medisse BV (Inactive) Company Overview
    • 5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 N8 Medical LLC Company Overview
    • 5.14.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Nanyang Technological University Company Overview
    • 5.15.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Northwestern University Company Overview
    • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 OptMed Inc Company Overview
    • 5.17.1 OptMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Purdue University Company Overview
    • 5.18.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Tissium SA Company Overview
    • 5.19.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of Galway Company Overview
    • 5.20.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 University of Kansas Company Overview
    • 5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Tissue Adhesives- Recent Developments

  • 6.1 Aug 30, 2024: Okapi Medical Receives 510(k) Clearance For Cutiva Topical Skin Adhesive
  • 6.2 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM005 Standard (CM005)
  • 6.3 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM00622 LINC Skin Closure System (CM00622 LINC)
  • 6.4 Jul 29, 2024: Connexicon Receives FDA 510(k) Clearance for CM004 Mini (CM004)
  • 6.5 Mar 22, 2024: Meril Endo Surgery Received FDA 510(K) Clearance For Meriglu Topical Skin Adhesive
  • 6.6 Oct 18, 2023: NeoDyne Launches New UK Headquarters to Mark Growth and Expansion in the UK

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer